• 915 Citations
  • 12 h-Index
1984 …2020
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

My laboratory focuses on understanding the molecular underpinnings of acquired and inherited retinal degenerations. Our goal is to develop novel therapies and restore vision for patients suffering from vision impairment secondary to retinal disease. Currently, the lab focuses on stem cell-like regenerative approaches to replace damaged or lost retinal cells.

Education/Academic qualification

MD, University of Missouri at Kansas City

BA in Liberal Arts, University of Missouri at Kansas City

Fingerprint Dive into the research topics where Sai Chavala is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Visual Acuity Medicine & Life Sciences
Uveitis Medicine & Life Sciences
Induced Pluripotent Stem Cells Medicine & Life Sciences
Ciliary Body Medicine & Life Sciences
Pathologic Neovascularization Medicine & Life Sciences
Retinal Neovascularization Medicine & Life Sciences
Optical Coherence Tomography Medicine & Life Sciences
Retinal Detachment Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2020

Research Output 1984 2019

  • 915 Citations
  • 12 h-Index
  • 27 Article
  • 6 Comment/debate
  • 2 Review article
  • 1 Chapter

Hybrid compound sa-2 is neuroprotective in animal models of retinal ganglion cell death

Stankowska, D. L., Dibas, A., Li, L., Zhang, W., Krishnamoorthy, V. R., Chavala, S. H., Nguyen, T. P., Yorio, T., Ellis, D. Z. & Acharya, S., Jul 2019, In : Investigative Ophthalmology and Visual Science. 60, 8, p. 3064-3073 10 p.

Research output: Contribution to journalArticle

Open Access
Retinal Ganglion Cells
Cell Death
Nerve Crush
Animal Models
Retina
1 Citation (Scopus)

Inhibition of Noncanonical Murine Double Minute 2 Homolog Abrogates Ocular Inflammation through NF-κB Suppression

Fan, Y., Zhang, W., Ni, A., Mahato, B. & Chavala, S., 1 Sep 2018, In : American Journal of Pathology. 188, 9, p. 2087-2096 10 p.

Research output: Contribution to journalArticle

Uveitis
Inflammation
Blindness
Pathologic Neovascularization
Therapeutics
3 Citations (Scopus)

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

Diabetic Retinopathy Clinical Research Network, 1 Jul 2018, In : Ophthalmology. 125, 7, p. 1054-1063 10 p.

Research output: Contribution to journalArticle

Endothelial Growth Factors
Macular Edema
Vascular Endothelial Growth Factor A
Therapeutics
Injections
8 Citations (Scopus)

Glycol Chitosan Engineered Autoregenerative Antioxidant Significantly Attenuates Pathological Damages in Models of Age-Related Macular Degeneration

Mitra, R. N., Gao, R., Zheng, M., Wu, M. J., Voinov, M. A., Smirnov, A. I., Smirnova, T. I., Wang, K., Chavala, S. & Han, Z., 23 May 2017, In : ACS Nano. 11, 5, p. 4669-4685 17 p.

Research output: Contribution to journalArticle

Oxidative stress
degeneration
antioxidants
Glycols
Antioxidants
5 Citations (Scopus)

Ambulatory blood pressure patterns in patients with retinal vein occlusion

Rao, V. N., Ulrich, J. N., Viera, A. J., Parlin, A., Fekrat, S. & Chavala, S. H., 1 Dec 2016, In : Retina. 36, 12, p. 2304-2310 7 p.

Research output: Contribution to journalArticle

Retinal Vein Occlusion
Blood Pressure
Masked Hypertension
Sleep
Confidence Intervals